Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...

October saw subdued growth in the Indian pharmaceutical market (IPM), with growth remaining in the low single digits, mainly ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...

The Nifty Pharma index closed on a note on Monday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Lupin Ltd.(up 0.99 per ...

Lupin’s average revenue will potentially increase 9.2 per cent Y-o-Y to Rs 5,502 crore as against Rs 5,038 crore in Q2FY24.

Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...

Torrent Pharmaceuticals Ltd delivering 10% year on year growth. Lupin Ltd , Abbott India Ltd, Glenmark Pharmaceuticals, Dr Reddy's Laboratories Ltd CIPLA Ltd and Zydus Lifesciences outperformed ...

In the September quarter, the pharma major’s US sales dipped sequentially to $220 million against $227 million in Q1FY25.

Glenmark Pharma has recently experienced profit-taking ... On the daily time frame, Lupin has broken down from a descending triangle pattern, signaling a negative trend. Sellers appear ...

NHPC, Lupin, Mahindra & Mahindra, Rail Vikas Nigam Ltd., and Trent are set to release their Q2 earnings today, with strong ...

Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...